ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae

ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae. A French, Observational, Prospective, Multicentric, Single Arm and Open Study

The objective of this study is to evaluate the safety and performance post last embolization with Onyx

Inclusion Criteria:

• The patient has an intracranial dAVF which could be treated by ONYX embolization, whether or not associated to other embolization products.
• The patient is at least 18 years of age.

Exclusion Criteria:

• The patient needs to be treated for the dAVF with another treatment option (for example by surgery) than embolization within a period of less than 6 months (to be counted as from the first treatment)
• The patient participates to another clinical study during the treatment period for his/her dAVF, evaluating another medical devices, procedure or medication.
• The patient refuses to give consent to the collection and processing of data required for centralized monitoring.
• A condition which could jeopardize follow-up of the patient.